Treasure Island: deproteinized extract of calf blood of the company is not produced at present
-
Last Update: 2016-08-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, some investors asked Treasure Island (603567) via SSE E interaction whether the company's calf blood deproteinized extract product was shut down and what proportion of such drugs accounted for the company's operating revenue? According to the reply of treasure island on August 5, deproteinized extract of calf blood of the company has not been produced yet, which accounted for 0.08% of the company's operating revenue in 2015 According to treasure island, the company's main product competitors are Kunming Pharmaceutical, Guangxi Wuzhou, Shenwei pharmaceutical, Jiangshi pharmaceutical, etc For investors' concerns: "the company's profit before income tax deduction in 2015 annual report is 650 million, why the cash of tax expense in that year reaches 430 million" Treasure Island explained that the company's total profit in 2015 was 690 million yuan, and tax expense was 430 million yuan The increase of company's tax is mainly due to the increase of company's operating revenue and profit.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
